Although uncommon in women less than 40 years old, breast cancer in younger women may have unique biologic and treatment implications. The purpose of this study was to evaluate treatment of breast cancer in young women with respect to previously established clinical predictors of local therapy choice.
There are over 3.0 million cases of nonmelanoma skin cancer (NMSC) diagnosed each year in the United States. Multiple treatment options exist for the treatment of these patients. We describe the outcomes of patients treated at a large private dermatology practice with electronic brachytherapy (eBx) who had a minimum follow-up duration of 1 year.
(P126) Student Institute to Stimulate Interest in Radiological Sciences Academic Careers (SISIRSAC): A Novel Near-Peer Mentoring Approach
The World Health Organization predicts that 26.4 million new cancer cases will be reported in 2030 alone. It is necessary to establish an effective mentoring paradigm in radiological science, not just for medical students (MS) but also for high school (HS) and college undergraduate (UG) students, to promote a greater general awareness of the study of oncology as well as its therapeutic implementation.
(P109) FDG-PET Feature and Texture Analysis as Potential Predictors of Pathologic Outcome Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Intriguing data suggest that clinical complete response following neoadjuvant chemoradiation (CRT) may obviate the need for definitive resection in patients with locally advanced rectal cancer.
(P125) Breast Cancer Outcomes With Anthracycline-Based Chemotherapy for Residual Disease Burden After Full-Dose Neoadjuvant Chemotherapy and Surgery Followed by Radiation Treatment
In breast cancer, the primary site residual burden of disease (PRBD) after neoadjuvant chemotherapy has been shown to correlate with poor prognostic outcomes. Currently, there is no established standard of care to offer patients with residual disease, in terms of adjuvant systemic treatment after full-dose neoadjuvant chemotherapy.
(S048) Impact of Breast Cancer Subtype in Locoregional Outcomes in Stage III Locally Advanced Breast Cancer (LABC) Treated With Modern Multimodality Therapy
The goal of this study is to assess locoregional outcomes associated with breast cancer subtype in stage III locally advanced breast cancer patients after surgery, radiation therapy, and modern systemic therapy.
(P154) Variation in Severity of Acute Skin Toxicity by Race and Ethnicity in a Prospective Cohort of Patients Receiving Postmastectomy Radiation
Risk factors for radiation-induced skin toxicity (ST) are poorly understood, and there are limited data examining the relationship between race/ethnicity and the development of ST. We evaluated risk factors for radiation-induced ST in a racially and ethnically diverse cohort of patients receiving postmastectomy radiation therapy (PMRT) for breast cancer.
(P153) Hypofractionated Radiation for Early Breast Cancer: What Are Reasonable Lung Dose Constraints in the Setting of 3-Dimensional Treatment Planning?
Our purpose is to review a series of hypofractionated plans to report our ipsilateral lung dose-volumes and corresponding lung included in the field at the central plane.
(S047) Racial and Ethnic Differences in the Diagnosis of Breast Cancer: Changes in Presenting Stage in Minority Populations in Florida From 1981–2009
We examined whether presenting stage at time of breast cancer diagnosis has changed over time in Florida and whether there is variation in this change with respect to race, ethnicity, and socioeconomic status.
Advances in radiotherapy technology have led to an increase in stereotactic body radiotherapy (SBRT) treatments.